Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia
- 1 November 1980
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 37 (3), 469-474
- https://doi.org/10.1016/0021-9150(80)90153-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effects of Probucol on Hyperlipidemic Patients with Cardiac AllograftsJournal of Cardiovascular Pharmacology, 1979
- ProbucolDrugs, 1978
- Diet and Probucol in Lowering Cholesterol ConcentrationsArchives of Internal Medicine, 1977
- Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemiaArchives of Internal Medicine, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Plasma Lipoproteins: Recent DevelopmentsPublished by Springer Nature ,1977
- Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese MenNew England Journal of Medicine, 1976
- Long‐Term Oral Administration of Probucol [4, 4‘‐(Isopropylidenedithio) bis (2, 6‐di‐t‐Butylphenol)] (DH‐581) in the Management of Hypercholesterolemia*Journal of the American Geriatrics Society, 1974
- Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemiaAtherosclerosis, 1972